Abstract
OBJECTIVE Although surgical treatment can provide significant improvement of symptomatic adult cervical spine deformity (ACSD), few reports have focused on the associated complications. The objective of this study was to assess complication rates at a minimum 1-year follow-up based on a prospective multicenter series of ACSD patients treated surgically. METHODS A prospective multicenter database of consecutive operative ACSD patients was reviewed for perioperative (< 30 days), early (30–90 days), and delayed (> 90 days) complications with a minimum 1-year follow-up. Enrollment required at least 1 of the following: cervical kyphosis > 10°, cervical scoliosis > 10°, C2–7 sagittal vertical axis > 4 cm, or chin-brow vertical angle > 25°. RESULTS Of 167 patients, 133 (80%, mean age 62 years, 62% women) had a minimum 1-year follow-up (mean 1.8 years). The most common diagnoses were degenerative (45%) and iatrogenic (17%) kyphosis. Almost 40% of patients were active or past smokers, 17% had osteoporosis, and 84% had at least 1 comorbidity. The mean baseline Neck Disability Index and modified Japanese Orthopaedic Association scores were 47 and 13.6, respectively. Surgical approaches were anterior-only (18%), posterior-only (47%), and combined (35%). A total of 132 complications were reported (54 minor and 78 major), and 74 (56%) patients had at least 1 complication. The most common complications included dysphagia (11%), distal junctional kyphosis (9%), respiratory failure (6%), deep wound infection (6%), new nerve root motor deficit (5%), and new sensory deficit (5%). A total of 4 deaths occurred that were potentially related to surgery, 2 prior to 1-year follow-up (1 cardiopulmonary and 1 due to obstructive sleep apnea and narcotic use) and 2 beyond 1-year followup (both cardiopulmonary and associated with revision procedures). Twenty-six reoperations were performed in 23 (17%) patients, with the most common indications of deep wound infection (n = 8), DJK (n = 7), and neurological deficit (n = 6). Although anterior-only procedures had a trend toward lower overall (42%) and major (21%) complications, rates were not significantly different from posterior-only (57% and 33%, respectively) or combined (61% and 37%, respectively) approaches (p = 0.29 and p = 0.38, respectively). CONCLUSIONS This report provides benchmark rates for ACSD surgery complications at a minimum 1-year (mean 1.8 years) follow-up. The marked health and functional impact of ACSD, the frail population it affects, and the high rates of surgical complications necessitate a careful risk-benefit assessment when contemplating surgery. Collectively, these findings provide benchmarks for complication rates and may prove useful for patient counseling and efforts to improve the safety of care.
Original language | English |
---|---|
Pages (from-to) | 588-600 |
Number of pages | 13 |
Journal | Journal of Neurosurgery: Spine |
Volume | 33 |
Issue number | 5 |
DOIs | |
State | Published - Nov 2020 |
Keywords
- Adult
- Cervical deformity
- Complications
- Surgery
Fingerprint
Dive into the research topics of 'Prospective multicenter assessment of complication rates associated with adult cervical deformity surgery in 133 patients with minimum 1-year follow-up'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of Neurosurgery: Spine, Vol. 33, No. 5, 11.2020, p. 588-600.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Prospective multicenter assessment of complication rates associated with adult cervical deformity surgery in 133 patients with minimum 1-year follow-up
AU - Smith, Justin S.
AU - Buell, Thomas J.
AU - Shaffrey, Christopher I.
AU - Kim, Han Jo
AU - Klineberg, Eric
AU - Protopsaltis, Themistocles
AU - Passias, Peter
AU - Mundis, Gregory M.
AU - Eastlack, Robert
AU - Deviren, Vedat
AU - Kelly, Michael P.
AU - Daniels, Alan H.
AU - Gum, Jeffrey L.
AU - Soroceanu, Alex
AU - Gupta, Munish
AU - Burton, Doug
AU - Hostin, Richard
AU - Hart, Robert
AU - Lafage, Virginie
AU - Lafage, Renaud
AU - Schwab, Frank J.
AU - Bess, Shay
AU - Ames, Christopher P.
N1 - Funding Information: The International Spine Study Group (ISSG) is funded through research grants from DePuy Synthes, Medtronic, and Globus. Dr. Smith: consultant for Zimmer Biomet, NuVasive, Stryker/ K2M, Cerapedics, DePuy Synthes/ISSG, and Carlsmed; stock ownership in Alphatec; royalties from Zimmer Biomet and NuVasive; and support of non–study-related clinical or research effort from DePuy Synthes/ISSG, AO Spine, and NuVasive. Dr. Shaffrey: consultant for NuVasive, Medtronic, and SI Bone; direct stock ownership in NuVasive; and patent holder with NuVasive, Medtronic, and Zimmer Biomet. Dr. Klineberg: consultant for DePuy Synthes, Stryker, and Medicrea; honoraria from AO Spine; and fellowship grant from AO Spine. Dr. Protopsaltis: consultant for Globus, Stryker K2M, Medicrea, NuVasive, and Innovasis; and royalties from Altus. Dr. Passias: consultant for Medicrea and Spinewave; support of non–study-related clinical or research effort from the Cervical Scoliosis Research Society; speakers bureau for Zimmer and Globus Medical; and other financial or material support from Allosource. Dr. Mundis: consultant for NuVasive, Stryker, Viseon, SeaSpine, and Carlsmed; direct stock ownership in NuVasive, Alphatec, and SeaSpine; patent holder with Stryker; and royalties from NuVasive and Stryker. Dr. Eastlack: consultant for Aesculap, Baxter, NuVasive, SeaSpine, SI Bone, Medtronic, Stryker, and Carevature; direct stock ownership in Spine Innovation, NuVasive, SeaSpine, Alphatec, and SI Bone; ownership in Spine Innovation; patent holder with SeaSpine, Globus, SI Bone, Invuity, and Spine Innovation; support of non–study-related clinical or research effort from SeaSpine, NuVasive, and Medtronic; speakers bureau for Radius; and royalties from NuVasive, SeaSpine, SI Bone, and Aesculap. Dr. Deviren: consultant for NuVasive, Medicrea, Biomet, SeaSpine, and Alphatec. Dr. Kelly: clinical or research support for the study described from DePuy Synthes Spine. Dr. Daniels: consultant for Medicrea, Spineart, Stryker, Orthofix, and Medtronic; and royalties from Medicrea, Spineart, Springer, and Southern Spine. Dr. Gum: employee of Norton Healthcare; consultant for Medtronic, DePuy, Stryker K2M, Acuity, and NuVasive; direct stock ownership in Cingulate Therapeutics; clinical or research support for the study described from Intellirod, Integra, Pfizer, and International Spine Study; patent holder with Medtronic; and royalties from Acuity. Dr. Gupta: consultant for DePuy and Medtronic; royalties from DePuy and Innomed; direct stock ownership in J&J and P&G; honoraria from AO Spine; and travel from Scoliosis Research Society; DePuy, Alphatec, Medtronic, Globus, AO Spine, Medicrea, Mizuho. Dr. Burton: consultant for Bioventus, patent holder with DePuy, and ownership in Progenerative Medical. Dr. Hart: consultant for DePuy, Globus, Medtronic, and Orthofix; royalties from SeaSpine; and support of non–study-related clinical or research effort from ISSLS. Dr. V. Lafage: consultant for Globus Medical; royalties from NuVasive; honoraria from The Permanente Medical Group, DePuy Synthes, and Implanet; and ownership in Nemaris Inc. Mr. R. Lafage: direct stock ownership in Nemaris. Dr. Schwab: consultant for Globus Medical, K2 Medical, and ZimmerBiomet; royalties from Medicrea USA, Medtronic Sofamor Danek USA, and Zimmer Biomet; honoraria from Zimmer Biomet; executive committee of ISSG. Dr. Bess: consultant for Stryker and mirus; direct stock ownership in Carlsmed and Progenitive Medicine; clinical or research support for the study described from DePuy Synthes and ISSGF; patent holder with K2M; royalties from Stryker and NuVaisve; and support of non–study-related clinical or research effort from ISSG. Dr. Ames: employee of UCSF; consultant for DePuy Synthes, Medtronic, Medicrea, and K2M; royalties from Stryker, Biomet Zimmer Spine, DePuy Synthes, NuVasive, Next Orthosurgical, K2M, Meidcrea; research support form Titan Spine, DePuy Synthes, and ISSG; editorial board of Operative Neurosurgery; grant funding from SRS, executive committee of ISSG, and director of Global Spinal Analytics. Funding Information: The International Spine Study Group (ISSG) is funded through research grants from DePuy Synthes, Medtronic, and Globus. Dr. Smith: consultant for Zimmer Biomet, NuVasive, Stryker/ K2M, Cerapedics, DePuy Synthes/ISSG, and Carlsmed; stock ownership in Alphatec; royalties from Zimmer Biomet and NuVasive; and support of non–study-related clinical or research effort from DePuy Synthes/ISSG, AO Spine, and NuVasive. Dr. Shaffrey: consultant for NuVasive, Medtronic, and SI Bone; direct stock ownership in NuVasive; and patent holder with NuVasive, Medtronic, and Zimmer Biomet. Dr. Klineberg: consultant for DePuy Synthes, Stryker, and Medicrea; honoraria from AO Spine; and fellowship grant from AO Spine. Dr. Protopsaltis: consultant for Globus, Stryker K2M, Medicrea, NuVasive, and Innovasis; and royalties from Altus. Dr. Passias: consultant for Medicrea and Spinewave; support of non–study-related clinical or research effort from the Cervical Scoliosis Research Society; speakers bureau for Zimmer and Globus Medical; and other financial or material support from Allosource. Dr. Mundis: consultant for NuVasive, Stryker, Viseon, SeaSpine, and Carlsmed; direct stock ownership in NuVasive, Alphatec, and SeaSpine; patent holder with Stryker; and royalties from NuVasive and Stryker. Dr. East-lack: consultant for Aesculap, Baxter, NuVasive, SeaSpine, SI Bone, Medtronic, Stryker, and Carevature; direct stock ownership in Spine Innovation, NuVasive, SeaSpine, Alphatec, and SI Bone; ownership in Spine Innovation; patent holder with SeaSpine, Globus, SI Bone, Invuity, and Spine Innovation; support of non– study-related clinical or research effort from SeaSpine, NuVasive, and Medtronic; speakers bureau for Radius; and royalties from NuVasive, SeaSpine, SI Bone, and Aesculap. Dr. Deviren: consultant for NuVasive, Medicrea, Biomet, SeaSpine, and Alphatec. Dr. Kelly: clinical or research support for the study described from DePuy Synthes Spine. Dr. Daniels: consultant for Medicrea, Spineart, Stryker, Orthofix, and Medtronic; and royalties from Medicrea, Spineart, Springer, and Southern Spine. Dr. Gum: employee of Norton Healthcare; consultant for Medtronic, DePuy, Stryker K2M, Acuity, and NuVasive; direct stock ownership in Cingulate Therapeutics; clinical or research support for the study described from Intellirod, Integra, Pfizer, and International Spine Study; patent holder with Medtronic; and royalties from Acuity. Dr. Gupta: consultant for DePuy and Medtronic; royalties from DePuy and Innomed; direct stock ownership in J&J and P&G; honoraria from AO Spine; and travel from Scoliosis Research Society; DePuy, Alphatec, Medtronic, Globus, AO Spine, Medi-crea, Mizuho. Dr. Burton: consultant for Bioventus, patent holder with DePuy, and ownership in Progenerative Medical. Dr. Hart: consultant for DePuy, Globus, Medtronic, and Orthofix; royalties from SeaSpine; and support of non–study-related clinical or research effort from ISSLS. Dr. V. Lafage: consultant for Globus Medical; royalties from NuVasive; honoraria from The Perman-ente Medical Group, DePuy Synthes, and Implanet; and ownership in Nemaris Inc. Mr. R. Lafage: direct stock ownership in Nemaris. Dr. Schwab: consultant for Globus Medical, K2 Medical, and ZimmerBiomet; royalties from Medicrea USA, Medtronic Sofamor Danek USA, and Zimmer Biomet; honoraria from Zimmer Biomet; executive committee of ISSG. Dr. Bess: consultant for Stryker and mirus; direct stock ownership in Carlsmed and Progenitive Medicine; clinical or research support for the study described from DePuy Synthes and ISSGF; patent holder with K2M; royalties from Stryker and NuVaisve; and support of non– study-related clinical or research effort from ISSG. Dr. Ames: employee of UCSF; consultant for DePuy Synthes, Medtronic, Medicrea, and K2M; royalties from Stryker, Biomet Zimmer Spine, DePuy Synthes, NuVasive, Next Orthosurgical, K2M, Meidcrea; research support form Titan Spine, DePuy Synthes, and ISSG; editorial board of Operative Neurosurgery; grant funding from SRS, executive committee of ISSG, and director of Global Spinal Analytics. Publisher Copyright: © AANS 2020, except where prohibited by US copyright law
PY - 2020/11
Y1 - 2020/11
N2 - OBJECTIVE Although surgical treatment can provide significant improvement of symptomatic adult cervical spine deformity (ACSD), few reports have focused on the associated complications. The objective of this study was to assess complication rates at a minimum 1-year follow-up based on a prospective multicenter series of ACSD patients treated surgically. METHODS A prospective multicenter database of consecutive operative ACSD patients was reviewed for perioperative (< 30 days), early (30–90 days), and delayed (> 90 days) complications with a minimum 1-year follow-up. Enrollment required at least 1 of the following: cervical kyphosis > 10°, cervical scoliosis > 10°, C2–7 sagittal vertical axis > 4 cm, or chin-brow vertical angle > 25°. RESULTS Of 167 patients, 133 (80%, mean age 62 years, 62% women) had a minimum 1-year follow-up (mean 1.8 years). The most common diagnoses were degenerative (45%) and iatrogenic (17%) kyphosis. Almost 40% of patients were active or past smokers, 17% had osteoporosis, and 84% had at least 1 comorbidity. The mean baseline Neck Disability Index and modified Japanese Orthopaedic Association scores were 47 and 13.6, respectively. Surgical approaches were anterior-only (18%), posterior-only (47%), and combined (35%). A total of 132 complications were reported (54 minor and 78 major), and 74 (56%) patients had at least 1 complication. The most common complications included dysphagia (11%), distal junctional kyphosis (9%), respiratory failure (6%), deep wound infection (6%), new nerve root motor deficit (5%), and new sensory deficit (5%). A total of 4 deaths occurred that were potentially related to surgery, 2 prior to 1-year follow-up (1 cardiopulmonary and 1 due to obstructive sleep apnea and narcotic use) and 2 beyond 1-year followup (both cardiopulmonary and associated with revision procedures). Twenty-six reoperations were performed in 23 (17%) patients, with the most common indications of deep wound infection (n = 8), DJK (n = 7), and neurological deficit (n = 6). Although anterior-only procedures had a trend toward lower overall (42%) and major (21%) complications, rates were not significantly different from posterior-only (57% and 33%, respectively) or combined (61% and 37%, respectively) approaches (p = 0.29 and p = 0.38, respectively). CONCLUSIONS This report provides benchmark rates for ACSD surgery complications at a minimum 1-year (mean 1.8 years) follow-up. The marked health and functional impact of ACSD, the frail population it affects, and the high rates of surgical complications necessitate a careful risk-benefit assessment when contemplating surgery. Collectively, these findings provide benchmarks for complication rates and may prove useful for patient counseling and efforts to improve the safety of care.
AB - OBJECTIVE Although surgical treatment can provide significant improvement of symptomatic adult cervical spine deformity (ACSD), few reports have focused on the associated complications. The objective of this study was to assess complication rates at a minimum 1-year follow-up based on a prospective multicenter series of ACSD patients treated surgically. METHODS A prospective multicenter database of consecutive operative ACSD patients was reviewed for perioperative (< 30 days), early (30–90 days), and delayed (> 90 days) complications with a minimum 1-year follow-up. Enrollment required at least 1 of the following: cervical kyphosis > 10°, cervical scoliosis > 10°, C2–7 sagittal vertical axis > 4 cm, or chin-brow vertical angle > 25°. RESULTS Of 167 patients, 133 (80%, mean age 62 years, 62% women) had a minimum 1-year follow-up (mean 1.8 years). The most common diagnoses were degenerative (45%) and iatrogenic (17%) kyphosis. Almost 40% of patients were active or past smokers, 17% had osteoporosis, and 84% had at least 1 comorbidity. The mean baseline Neck Disability Index and modified Japanese Orthopaedic Association scores were 47 and 13.6, respectively. Surgical approaches were anterior-only (18%), posterior-only (47%), and combined (35%). A total of 132 complications were reported (54 minor and 78 major), and 74 (56%) patients had at least 1 complication. The most common complications included dysphagia (11%), distal junctional kyphosis (9%), respiratory failure (6%), deep wound infection (6%), new nerve root motor deficit (5%), and new sensory deficit (5%). A total of 4 deaths occurred that were potentially related to surgery, 2 prior to 1-year follow-up (1 cardiopulmonary and 1 due to obstructive sleep apnea and narcotic use) and 2 beyond 1-year followup (both cardiopulmonary and associated with revision procedures). Twenty-six reoperations were performed in 23 (17%) patients, with the most common indications of deep wound infection (n = 8), DJK (n = 7), and neurological deficit (n = 6). Although anterior-only procedures had a trend toward lower overall (42%) and major (21%) complications, rates were not significantly different from posterior-only (57% and 33%, respectively) or combined (61% and 37%, respectively) approaches (p = 0.29 and p = 0.38, respectively). CONCLUSIONS This report provides benchmark rates for ACSD surgery complications at a minimum 1-year (mean 1.8 years) follow-up. The marked health and functional impact of ACSD, the frail population it affects, and the high rates of surgical complications necessitate a careful risk-benefit assessment when contemplating surgery. Collectively, these findings provide benchmarks for complication rates and may prove useful for patient counseling and efforts to improve the safety of care.
KW - Adult
KW - Cervical deformity
KW - Complications
KW - Surgery
UR - http://www.scopus.com/inward/record.url?scp=85091703381&partnerID=8YFLogxK
U2 - 10.3171/2020.4.SPINE20213
DO - 10.3171/2020.4.SPINE20213
M3 - Article
C2 - 32559746
AN - SCOPUS:85091703381
SN - 1547-5654
VL - 33
SP - 588
EP - 600
JO - Journal of Neurosurgery: Spine
JF - Journal of Neurosurgery: Spine
IS - 5
ER -